MEDLINE INDUSTRIES LIMITEDActive
Key figures
MEDLINE INDUSTRIES LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2024Balance sheet structure
Dividends
from the accountsDividends paid in the financial year: £1,000,000 (129% of the profit for the year).
Filed accounts2022–2024
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Profit for the year | 1,023,163 | 773,527 | 843,968 |
| Cash at bank and in hand | 6,781,033 | 6,699,956 | 4,324,104 |
| Total assets | 15,637,296 | 15,923,120 | 15,816,695 |
| Total liabilities | 8,533,540 | 9,031,278 | — |
| Net assets / total equity | 7,221,659 | 6,995,186 | 7,839,154 |
| Average number of employees | 47 | 45 | 0 |
| Average pay (per year) | 69,416 | 101,384 | — |
| Dividends paid | — | 1,000,000 | — |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2024The principle activity of the company is the distribution of medical products.
As described in the company's latest filed accounts.
Summary: MEDLINE INDUSTRIES LIMITED
Company
MEDLINE INDUSTRIES LIMITED is a private limited company registered with Companies House under company number 03238147. It was incorporated on 15 Aug 1996. Its status is active. The registered office is in Warrington (WA4). Its nature of business (SIC 2007) is other business support service activities n.e.c. (82990).
Accounts
The latest accounts in the database are for 2024 (period ending 31 Dec 2024); the company files full accounts. Profit for the year was £843,968. Net assets were £7,839,154, up 12.1% on the previous year. Cash at bank and in hand was £4,324,104. The company had an average of 0 employees. Figures are available for 3 financial years (2022–2024).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 18 Aug 2027.